China Historical Balance Sheet

600511 Stock

32.56 0.18 0.55%

Trend analysis of China National Medicines balance sheet accounts such as Other Current Liab of 1.3 M, Total Current Liabilities of 16.8 B or Total Stockholder Equity of 19 B provides information on China National's total assets, liabilities, and equity, which is the actual value of China National Medicines to its prevalent stockholders. By breaking down trends over time using China National balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining China National Medicines latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether China National Medicines is a good buy for the upcoming year.

China National Inventory

4.78 Billion

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China National Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About China Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of China National Medicines at a specified time, usually calculated after every quarter, six months, or one year. China National Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of China National and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which China currently owns. An asset can also be divided into two categories, current and non-current.

China National Balance Sheet Chart

At present, China National's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 16.8 B, whereas Other Current Liabilities is forecasted to decline to about 1.3 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Total Assets

Total assets refers to the total amount of China National assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in China National Medicines books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on China National balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of China National Medicines are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from China National's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into China National Medicines current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China National Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	1.0M	1.2M	1.4M	1.3M
Total Assets	29.6B	32.5B	37.3B	39.2B

Other Current Liab Total Assets

China National balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Accounts Payable	Cash	Other Assets	Net Receivables	Inventory	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Retained Earnings	Long Term Debt	Intangible Assets	Other Liab	Short Term Investments	Good Will	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Total Current Assets	Non Current Assets Total	Non Currrent Assets Other
Total Assets		0.07	0.97	1.0	0.96	0.98	0.96	0.75	0.96	-0.07	1.0	0.7	0.89	0.98	-0.43	0.99	0.87	0.48	0.92	0.93	-0.9	0.91	0.86	0.94	0.91	0.84
Other Current Liab	0.07		0.19	0.01	0.19	-0.09	0.13	0.32	0.15	0.88	0.11	0.42	0.18	-0.03	-0.16	0.16	-0.22	0.13	0.3	0.21	-0.38	0.16	0.27	0.17	-0.13	-0.33
Total Current Liabilities	0.97	0.19		0.96	1.0	0.94	0.97	0.85	1.0	0.02	0.97	0.72	0.9	0.96	-0.47	0.97	0.82	0.51	0.89	0.92	-0.91	0.87	0.84	0.96	0.84	0.76
Total Stockholder Equity	1.0	0.01	0.96		0.96	0.99	0.96	0.72	0.96	-0.13	0.99	0.67	0.89	0.99	-0.43	0.98	0.89	0.47	0.9	0.92	-0.86	0.91	0.85	0.94	0.92	0.86
Accounts Payable	0.96	0.19	1.0	0.96		0.93	0.97	0.85	0.99	0.02	0.96	0.71	0.9	0.96	-0.46	0.97	0.82	0.51	0.88	0.92	-0.9	0.87	0.85	0.96	0.84	0.76
Cash	0.98	-0.09	0.94	0.99	0.93		0.94	0.71	0.94	-0.23	0.97	0.61	0.85	0.99	-0.43	0.96	0.91	0.44	0.86	0.89	-0.82	0.87	0.8	0.91	0.92	0.88
Other Assets	0.96	0.13	0.97	0.96	0.97	0.94		0.76	0.97	-0.01	0.96	0.75	0.91	0.96	-0.3	0.94	0.88	0.63	0.87	0.91	-0.86	0.88	0.81	0.92	0.85	0.79
Net Receivables	0.75	0.32	0.85	0.72	0.85	0.71	0.76		0.86	0.25	0.77	0.65	0.71	0.72	-0.43	0.8	0.48	0.48	0.71	0.7	-0.83	0.58	0.67	0.77	0.56	0.44
Inventory	0.96	0.15	1.0	0.96	0.99	0.94	0.97	0.86		0.02	0.96	0.72	0.91	0.96	-0.43	0.97	0.82	0.55	0.87	0.91	-0.9	0.86	0.85	0.95	0.84	0.76
Other Current Assets	-0.07	0.88	0.02	-0.13	0.02	-0.23	-0.01	0.25	0.02		-0.02	0.35	0.04	-0.18	0.11	0.0	-0.35	0.16	0.15	0.04	-0.26	-0.03	0.16	0.0	-0.25	-0.47
Total Liab	1.0	0.11	0.97	0.99	0.96	0.97	0.96	0.77	0.96	-0.02		0.73	0.89	0.97	-0.42	0.99	0.84	0.49	0.93	0.93	-0.92	0.9	0.86	0.94	0.89	0.81
Common Stock	0.7	0.42	0.72	0.67	0.71	0.61	0.75	0.65	0.72	0.35	0.73		0.73	0.63	-0.05	0.72	0.49	0.65	0.82	0.8	-0.79	0.76	0.81	0.78	0.68	0.43
Property Plant Equipment	0.89	0.18	0.9	0.89	0.9	0.85	0.91	0.71	0.91	0.04	0.89	0.73		0.9	-0.24	0.89	0.74	0.69	0.8	0.83	-0.76	0.82	0.77	0.83	0.77	0.74
Retained Earnings	0.98	-0.03	0.96	0.99	0.96	0.99	0.96	0.72	0.96	-0.18	0.97	0.63	0.9		-0.43	0.96	0.91	0.47	0.86	0.91	-0.83	0.9	0.83	0.93	0.92	0.87
Long Term Debt	-0.43	-0.16	-0.47	-0.43	-0.46	-0.43	-0.3	-0.43	-0.43	0.11	-0.42	-0.05	-0.24	-0.43		-0.49	-0.25	0.39	-0.46	-0.47	0.51	-0.43	-0.43	-0.49	-0.37	-0.33
Intangible Assets	0.99	0.16	0.97	0.98	0.97	0.96	0.94	0.8	0.97	0.0	0.99	0.72	0.89	0.96	-0.49		0.8	0.45	0.94	0.93	-0.93	0.9	0.87	0.95	0.87	0.8
Other Liab	0.87	-0.22	0.82	0.89	0.82	0.91	0.88	0.48	0.82	-0.35	0.84	0.49	0.74	0.91	-0.25	0.8		0.46	0.7	0.79	-0.63	0.79	0.67	0.8	0.87	0.81
Short Term Investments	0.48	0.13	0.51	0.47	0.51	0.44	0.63	0.48	0.55	0.16	0.49	0.65	0.69	0.47	0.39	0.45	0.46		0.34	0.36	-0.36	0.33	0.32	0.38	0.33	0.34
Good Will	0.92	0.3	0.89	0.9	0.88	0.86	0.87	0.71	0.87	0.15	0.93	0.82	0.8	0.86	-0.46	0.94	0.7	0.34		0.97	-0.95	0.95	0.95	0.95	0.87	0.69
Net Tangible Assets	0.93	0.21	0.92	0.92	0.92	0.89	0.91	0.7	0.91	0.04	0.93	0.8	0.83	0.91	-0.47	0.93	0.79	0.36	0.97		-0.91	0.98	0.96	0.99	0.93	0.75
Other Stockholder Equity	-0.9	-0.38	-0.91	-0.86	-0.9	-0.82	-0.86	-0.83	-0.9	-0.26	-0.92	-0.79	-0.76	-0.83	0.51	-0.93	-0.63	-0.36	-0.95	-0.91		-0.84	-0.89	-0.91	-0.77	-0.6
Deferred Long Term Liab	0.91	0.16	0.87	0.91	0.87	0.87	0.88	0.58	0.86	-0.03	0.9	0.76	0.82	0.9	-0.43	0.9	0.79	0.33	0.95	0.98	-0.84		0.94	0.95	0.95	0.79
Long Term Investments	0.86	0.27	0.84	0.85	0.85	0.8	0.81	0.67	0.85	0.16	0.86	0.81	0.77	0.83	-0.43	0.87	0.67	0.32	0.95	0.96	-0.89	0.94		0.93	0.88	0.66
Total Current Assets	0.94	0.17	0.96	0.94	0.96	0.91	0.92	0.77	0.95	0.0	0.94	0.78	0.83	0.93	-0.49	0.95	0.8	0.38	0.95	0.99	-0.91	0.95	0.93		0.93	0.76
Non Current Assets Total	0.91	-0.13	0.84	0.92	0.84	0.92	0.85	0.56	0.84	-0.25	0.89	0.68	0.77	0.92	-0.37	0.87	0.87	0.33	0.87	0.93	-0.77	0.95	0.88	0.93		0.86
Non Currrent Assets Other	0.84	-0.33	0.76	0.86	0.76	0.88	0.79	0.44	0.76	-0.47	0.81	0.43	0.74	0.87	-0.33	0.8	0.81	0.34	0.69	0.75	-0.6	0.79	0.66	0.76	0.86

Click cells to compare fundamentals

China National Account Relationship Matchups

China National balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	24.9B	27.5B	29.6B	32.5B	37.3B	39.2B
Other Current Liab	1.2B	1.5B	1.0M	1.2M	1.4M	1.3M
Total Current Liabilities	11.2B	12.7B	12.7B	13.9B	16.0B	16.8B
Total Stockholder Equity	11.4B	12.8B	14.2B	15.8B	18.1B	19.0B
Accounts Payable	9.0B	10.1B	9.9B	10.9B	12.6B	13.2B
Cash	6.2B	7.3B	8.9B	10.9B	12.6B	13.2B
Other Assets	242.6M	283.9M	299.0M	345.4M	397.2M	417.1M
Net Receivables	5.4B	5.7B	5.7B	9.0B	10.3B	10.8B
Inventory	3.0B	3.5B	3.7B	4.0B	4.6B	4.8B
Other Current Assets	198.6M	280.6M	14.5M	8.7M	10.0M	9.5M
Total Liab	11.8B	13.1B	13.7B	14.9B	17.2B	18.0B
Property Plant Equipment	628.5M	832.7M	895.7M	845.1M	971.8M	1.0B
Retained Earnings	8.3B	9.7B	10.5B	12.0B	13.8B	14.5B
Intangible Assets	330.4M	326.2M	330.9M	386.1M	444.0M	466.2M
Other Liab	233.2M	265.0M	313.7M	718.4M	826.2M	867.5M
Net Tangible Assets	8.8B	10.1B	11.0B	12.3B	14.2B	9.2B
Other Stockholder Equity	15.9M	22.5M	27.7M	24.9M	22.4M	25.5M
Deferred Long Term Liab	56.8M	71.8M	90.3M	89.6M	103.0M	68.2M
Total Current Assets	22.1B	24.5B	25.8B	28.3B	32.5B	22.0B
Non Current Assets Total	2.8B	3.0B	3.8B	4.2B	4.8B	3.0B
Non Currrent Assets Other	674.8M	139.6M	686.7M	686.0M	789.0M	828.4M
Non Current Liabilities Total	573.8M	491.1M	1.0B	1.0B	1.2B	1.2B
Non Current Liabilities Other	178.1M	226.6M	215.2M	747.1M	859.2M	902.2M
Net Invested Capital	11.9B	13.2B	14.5B	16.0B	18.5B	13.5B
Short Long Term Debt	471.8M	428.8M	252.1M	268.4M	241.5M	456.0M
Net Working Capital	10.9B	11.8B	13.0B	14.4B	16.5B	12.1B
Property Plant And Equipment Net	895.7M	845.1M	857.9M	827.0M	744.3M	681.4M
Capital Lease Obligations	260.1M	197.3M	182.6M	205.1M	184.6M	161.9M
Property Plant And Equipment Gross	1.3B	1.4B	1.4B	827.0M	744.3M	992.3M

Currently Active Assets on Macroaxis

S	SentinelOne
CRM	Salesforce
MSFT	Microsoft
GOOG	Alphabet Inc Class C
GM	General Motors

Other Information on Investing in China Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

China Historical Balance Sheet

China National Inventory

4.78 Billion

About China Balance Sheet Analysis

China National Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

China National balance sheet Correlations

China National Account Relationship Matchups

High Positive Relationship

High Negative Relationship

China National balance sheet Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in China Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities
Inventory	+ 1.0	Total Current Liabilities
Intangible Assets	+ 0.99	Total Assets
Cash	+ 0.99	Total Stockholder Equity

Other Stockholder Equity	- 0.95	Good Will
Other Stockholder Equity	- 0.93	Intangible Assets
Other Stockholder Equity	- 0.92	Total Liab
Total Current Assets	- 0.91	Other Stockholder Equity
Other Stockholder Equity	- 0.91	Net Tangible Assets
Other Stockholder Equity	- 0.91	Total Current Liabilities